GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Net Change in Cash

Psyence Biomedical (Psyence Biomedical) Net Change in Cash : $-0.28 Mil (TTM As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Psyence Biomedical's Net Change in Cash for the six months ended in Mar. 2023 was $-0.28 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.28 Mil.

Psyence Biomedical Net Change in Cash Historical Data

The historical data trend for Psyence Biomedical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Net Change in Cash Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Net Change in Cash
- -3.01 -0.28

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Net Change in Cash - -3.01 -0.28

Psyence Biomedical Net Change in Cash Calculation

Psyence Biomedical's Net Change in Cash for the fiscal year that ended in Mar. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-1.416+0+1.134+0
=-0.28

Psyence Biomedical's Net Change in Cash for the quarter that ended in Mar. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-1.416+0+1.134+0
=-0.28

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psyence Biomedical Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Net Change in Cash
Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Website
https://www.psyence.com
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024